应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02179 瑞科生物-B
未开盘 07-11 16:08:03
7.720
-0.180
-2.28%
最高
7.900
最低
7.650
成交量
4.80万
今开
7.900
昨收
7.900
日振幅
3.16%
总市值
37.28亿
流通市值
24.41亿
总股本
4.83亿
成交额
37.21万
换手率
0.02%
流通股本
3.16亿
市净率
6.44
ROE
-70.23%
每股收益
-1.27
52周最高
9.800
52周最低
6.760
市盈率
-6.06
股息
0.00
股息收益率
0.00
ROA
-17.32%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
不到进口一半!国产九价HPV疫苗定价来了,单支499元
每日经济新闻 · 07-08
不到进口一半!国产九价HPV疫苗定价来了,单支499元
【瑞科生物-B(02179.HK)与印度Biological E公司就重组九价HPV疫苗REC603达成产品授权合作】智
智通财经 · 06-30
【瑞科生物-B(02179.HK)与印度Biological E公司就重组九价HPV疫苗REC603达成产品授权合作】智
瑞科生物与印度Biological E公司就重组九价HPV疫苗达成产品授权合作
界面 · 06-30
瑞科生物与印度Biological E公司就重组九价HPV疫苗达成产品授权合作
瑞科生物-B(02179):陈刚获委任为第二届董事会观察员
智通财经 · 06-20
瑞科生物-B(02179):陈刚获委任为第二届董事会观察员
【瑞科生物-B(02179.HK):陈刚获委任为第二届董事会观察员】智通财经APP讯,瑞科生物-B(02179.HK)发
智通财经 · 06-20
【瑞科生物-B(02179.HK):陈刚获委任为第二届董事会观察员】智通财经APP讯,瑞科生物-B(02179.HK)发
瑞科生物拟参与H股全流通计划并计划变更经营范围
财中社 · 05-21
瑞科生物拟参与H股全流通计划并计划变更经营范围
瑞科生物-B拟参与H股全流通计划
格隆汇 · 05-21
瑞科生物-B拟参与H股全流通计划
中关村科技租赁(01601)就配液系统等疫苗生产设备与江苏瑞科生物技术订立融资租赁协议
智通财经 · 04-16
中关村科技租赁(01601)就配液系统等疫苗生产设备与江苏瑞科生物技术订立融资租赁协议
瑞科生物-B(02179)定向发行内资股申请材料获中国证监会受理
智通财经 · 02-27
瑞科生物-B(02179)定向发行内资股申请材料获中国证监会受理
瑞科生物-B盘中异动 早盘大幅下跌9.88%报8.210港元
市场透视 · 02-17
瑞科生物-B盘中异动 早盘大幅下跌9.88%报8.210港元
瑞科生物-B盘中异动 急速下挫10.79%报8.100港元
市场透视 · 02-14
瑞科生物-B盘中异动 急速下挫10.79%报8.100港元
瑞科生物九价HPV疫苗获新进展,股价竟萎靡不振?
财华社 · 02-13
瑞科生物九价HPV疫苗获新进展,股价竟萎靡不振?
瑞科生物(02179.HK)重组九价HPV疫苗临床试验申请获受理
阿斯达克财经 · 02-12
瑞科生物(02179.HK)重组九价HPV疫苗临床试验申请获受理
【瑞科生物-B(02179.HK)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理】瑞科生物-B(02179.HK)发布公告,集团已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c (REC604c)临床试验申请。
金融界 · 02-12
【瑞科生物-B(02179.HK)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理】瑞科生物-B(02179.HK)发布公告,集团已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c (REC604c)临床试验申请。
瑞科生物-B(02179)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理
智通财经 · 02-12
瑞科生物-B(02179)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理
瑞科生物-B盘中异动 股价大涨5.30%报9.140港元
市场透视 · 02-12
瑞科生物-B盘中异动 股价大涨5.30%报9.140港元
瑞科生物-B(02179)股价上升5.3%,现价港币$9.14
阿斯达克财经 · 02-12
瑞科生物-B(02179)股价上升5.3%,现价港币$9.14
瑞科生物-B盘中异动 早盘急速上涨5.08%报8.680港元
市场透视 · 02-11
瑞科生物-B盘中异动 早盘急速上涨5.08%报8.680港元
瑞科生物-B(02179)股价上升5.085%,现价港币$8.68
阿斯达克财经 · 02-11
瑞科生物-B(02179)股价上升5.085%,现价港币$8.68
瑞科生物-B盘中异动 临近收盘股价大跌6.02%
市场透视 · 01-09
瑞科生物-B盘中异动 临近收盘股价大跌6.02%
加载更多
公司概况
公司名称:
瑞科生物-B
所属市场:
SEHK
上市日期:
2022-03-31
主营业务:
江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。该公司拥有一系列临床和临床前阶段的疫苗,人乳头瘤病毒(HPV)疫苗管线包括重组HPV九价候选疫苗REC603,重组HPV二价候选疫苗REC601及REC602,重组HPV四价疫苗REC604a以及重组HPV九价疫苗REC604b。该公司还参与新冠病毒疫苗的研发。该公司主要在国内市场销售其产品。
发行价格:
24.800
{"stockData":{"symbol":"02179","market":"HK","secType":"STK","nameCN":"瑞科生物-B","latestPrice":7.72,"timestamp":1752221283029,"preClose":7.9,"halted":0,"volume":48000,"delay":0,"floatShares":316138689,"shares":482963000,"eps":-1.274604314391561,"marketStatus":"未开盘","change":-0.18,"latestTime":"07-11 16:08:03","open":7.9,"high":7.9,"low":7.65,"amount":372085,"amplitude":0.031646,"askPrice":7.77,"askSize":25500,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.274604314391561,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752456600000},"marketStatusCode":0,"adr":0,"listingDate":1648656000000,"exchange":"SEHK","adjPreClose":7.9,"openAndCloseTimeList":[[1752197400000,1752206400000],[1752210000000,1752220800000]],"volumeRatio":9.411764982698969,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02179","defaultTab":"news","newsList":[{"id":"2550524084","title":"不到进口一半!国产九价HPV疫苗定价来了,单支499元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550524084","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550524084?lang=zh_cn&edition=full","pubTime":"2025-07-09 00:54","pubTimestamp":1751993651,"startTime":"0","endTime":"0","summary":"每经记者:陈星每经编辑:陈柯名,文多7月8日,首个国产九价HPV疫苗公布定价。另一边,按照目前公布的市场价格,默沙东旗下的进口九价HPV疫苗价格约为1318元/支。同时,针对外界关注的疫苗保护率问题,公司方面提到,九价HPV疫苗对相关持续感染的保护率超过98%。九价疫苗价格战或刚刚开始虽然万泰生物成为首个国产九价HPV疫苗的拥有者。但无论国内外厂家,都需要直面HPV疫苗接种高峰已经过去的现实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709010047a43e7859&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709010047a43e7859&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179","BK1589","BK1200","LU1981816686.USD","09633"],"gpt_icon":0},{"id":"2547062753","title":"【瑞科生物-B(02179.HK)与印度Biological E公司就重组九价HPV疫苗REC603达成产品授权合作】智","url":"https://stock-news.laohu8.com/highlight/detail?id=2547062753","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547062753?lang=zh_cn&edition=full","pubTime":"2025-06-30 17:36","pubTimestamp":1751276195,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0444973449.USD","159646","LU1642822529.SGD","LU0476273544.USD","LU1815336760.USD","02179","LU0823414551.USD","LU0823414478.USD","BK1161","MNDmain","LU0444971666.USD","BK4588","LU2506951792.HKD","BK4182","LU2249611893.SGD","LU2294711713.HKD","LU0957808578.USD","BK4541","LU2357125470.USD","BK4585","BE"],"gpt_icon":0},{"id":"2547506985","title":"瑞科生物与印度Biological E公司就重组九价HPV疫苗达成产品授权合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2547506985","media":"界面","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547506985?lang=zh_cn&edition=full","pubTime":"2025-06-30 16:55","pubTimestamp":1751273716,"startTime":"0","endTime":"0","summary":"6月30日,瑞科生物宣布,公司与印度生物制品公司Biological E (下称“BE公司”)就重组九价HPV疫苗REC603签署产品授权合作协议。瑞科生物将向BE公司转移疫苗配制及分包装技术,并在适当时机转移原液生产技术。据协议,BE公司被独家授权在印度及由联合国儿童基金会(UNICEF)、泛美卫生组织(PAHO)主导的招标市场开发,生产及商业化重组九价HPV疫苗。目前,瑞科生物已收到合作预付款,并将按合作进度收取里程碑付款,以及基于一定比例年净销售额的特许权使用费。(界面新闻记者 陈杨)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630165517a4c63017&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630165517a4c63017&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2544258721","title":"瑞科生物-B(02179):陈刚获委任为第二届董事会观察员","url":"https://stock-news.laohu8.com/highlight/detail?id=2544258721","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544258721?lang=zh_cn&edition=full","pubTime":"2025-06-20 17:59","pubTimestamp":1750413569,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞科生物-B(02179)发布公告,于年度股东大会上,陈刚先生获委任为公司第二届董事会观察员。陈先生的任期自年度股东大会批准之日起,至第二届董事会任期届满之日止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1307812.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2544123056","title":"【瑞科生物-B(02179.HK):陈刚获委任为第二届董事会观察员】智通财经APP讯,瑞科生物-B(02179.HK)发","url":"https://stock-news.laohu8.com/highlight/detail?id=2544123056","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544123056?lang=zh_cn&edition=full","pubTime":"2025-06-20 17:59","pubTimestamp":1750413569,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2537981507","title":"瑞科生物拟参与H股全流通计划并计划变更经营范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2537981507","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537981507?lang=zh_cn&edition=full","pubTime":"2025-05-21 18:11","pubTimestamp":1747822260,"startTime":"0","endTime":"0","summary":"5月21日,瑞科生物-B发布公告,宣布公司拟参与H股全流通计划,计划将1.42亿股未上市股份转为H股。此次H股全流通申请意向股数占未上市股份比例为85.09%,占公司总股本比例为29.39%。完成后,H股总数将变更为4.58亿股,H股占总股本比例将提升至94.85%。此外,公司还计划变更经营范围,具体包括药品生产、生物基材料技术研发与制造等。上述变更需在股东大会上通过相关决议后方可生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052118164294fdd2a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052118164294fdd2a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2537985755","title":"瑞科生物-B拟参与H股全流通计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2537985755","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537985755?lang=zh_cn&edition=full","pubTime":"2025-05-21 17:39","pubTimestamp":1747820384,"startTime":"0","endTime":"0","summary":"格隆汇5月21日丨瑞科生物-B(02179.HK)发布公告,董事会已于2025年5月21日审议批准,拟将公司约1.42亿股未上市股份转换为公司H股(“本次H股全流通”)。在取得所有相关备案及批准(包括中国证监会备案及联交所批准)及符合所有适用的法律、规则及法规后,有关未上市股份将被转换为H股,公司将向联交所申请该等H股于主板上市及买卖(“转换及上市”)。此外,董事会于2025年5月21日召开董事会会议,选举陈青青担任第二届董事会提名委员会委员。陈青青的任期自董事会审议通过之日起,至第二届董事会届满之日止。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521173945a48698d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521173945a48698d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2527216729","title":"中关村科技租赁(01601)就配液系统等疫苗生产设备与江苏瑞科生物技术订立融资租赁协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2527216729","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527216729?lang=zh_cn&edition=full","pubTime":"2025-04-16 20:22","pubTimestamp":1744806174,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中关村科技租赁 发布公告,于2025年4月16日,公司作为出租人与承租人江苏瑞科生物技术股份有限公司订立融资租赁协议II,据此,出租人将购入承租人自有租赁资产II,转让价款为人民币4800万元;及出租人将租赁资产II租回给承租人,租赁期为36个月,总租赁款项约为人民币5164.93万元,包括融资租赁本金为人民币4800万元及融资租赁利息收入约为人民币364.93万元。租赁资产II为配液系统等疫苗生产设备,账面净值约为人民币5333.12万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1279716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1186","159646","BK1161","01601","02179"],"gpt_icon":0},{"id":"2514870636","title":"瑞科生物-B(02179)定向发行内资股申请材料获中国证监会受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2514870636","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514870636?lang=zh_cn&edition=full","pubTime":"2025-02-27 19:21","pubTimestamp":1740655278,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞科生物-B(02179)发布公告,有关(其中包括)本公司建议定向发行内资股及其相关事宜已获临时股东大会审议批准的相关事宜。本公司于近日收到中国证监会出具的《中国证监会行政许可申请受理单》(受理序号:250162)。中国证监会依法对本公司提交的申请材料进行了审查,认为该申请材料齐全,决定对该行政许可申请予以受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2512964914","title":"瑞科生物-B盘中异动 早盘大幅下跌9.88%报8.210港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512964914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512964914?lang=zh_cn&edition=full","pubTime":"2025-02-17 09:32","pubTimestamp":1739755975,"startTime":"0","endTime":"0","summary":"2025年02月17日早盘09时32分,瑞科生物-B股票出现波动,股价快速跳水9.88%。截至发稿,该股报8.210港元/股,成交量7500股,换手率0.00%,振幅9.77%。资金方面,该股资金流入0港元,流出5.881万港元。瑞科生物-B股票所在的生物技术行业中,整体涨幅为0.70%。其相关个股中,科济药业-B、晶泰控股-P、基石药业-B涨幅较大,振幅较大的相关个股有科笛-B、瑞科生物-B、基石药业-B,振幅分别为9.88%、9.77%、7.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502170932569887fd26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502170932569887fd26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2511471686","title":"瑞科生物-B盘中异动 急速下挫10.79%报8.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511471686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511471686?lang=zh_cn&edition=full","pubTime":"2025-02-14 10:15","pubTimestamp":1739499309,"startTime":"0","endTime":"0","summary":"2025年02月14日早盘10时15分,瑞科生物-B股票出现波动,股价急速下跌10.79%。截至发稿,该股报8.100港元/股,成交量6.8万股,换手率0.02%,振幅13.33%。瑞科生物-B股票所在的生物技术行业中,整体涨幅为2.67%。瑞科生物-B公司简介:江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。消息层面,截至10时15分,《瑞科生物-B新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理》资讯为影响瑞科生物-B的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141015099884ccc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141015099884ccc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2511513713","title":"瑞科生物九价HPV疫苗获新进展,股价竟萎靡不振?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511513713","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511513713?lang=zh_cn&edition=full","pubTime":"2025-02-13 14:32","pubTimestamp":1739428349,"startTime":"0","endTime":"0","summary":"2月12日,港股的瑞科生物(02179.HK)发布公告称,公司近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c的临床试验申请。","market":"hk","thumbnail":"https://images.finet.hk/photoLib/title/202502_1/6430a70d-5888-476d-8512-761dc83ea647.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202502_1/6430a70d-5888-476d-8512-761dc83ea647.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67ad91fd5a7712d0652496cc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2511030417","title":"瑞科生物(02179.HK)重组九价HPV疫苗临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2511030417","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511030417?lang=zh_cn&edition=full","pubTime":"2025-02-13 00:26","pubTimestamp":1739377560,"startTime":"0","endTime":"0","summary":"瑞科生物-B(02179.HK) 公布,近日收到国家药品监督管理局通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c临床试验申请。REC604c是公司计划针对男性市场和升级市场开发的新型重组九价HPV疫苗。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200103175221798_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200103175221798_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1416820/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","BK1141","03347","BK1576","02179","BK1583","159646"],"gpt_icon":0},{"id":"2510376095","title":"【瑞科生物-B(02179.HK)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理】瑞科生物-B(02179.HK)发布公告,集团已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c (REC604c)临床试验申请。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510376095","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510376095?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:55","pubTimestamp":1739364948,"startTime":"0","endTime":"0","summary":"瑞科生物-B(02179.HK)发布公告,集团已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c (REC604c)临床试验申请。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12205548120638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1576","BK1583","159646","02179","BK1161","BK1141","03347"],"gpt_icon":0},{"id":"2510376959","title":"瑞科生物-B(02179)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2510376959","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510376959?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:46","pubTimestamp":1739364391,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞科生物-B 发布公告,集团已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c 临床试验申请。REC604c是公司计划针对男性市场和升级市场开发的新型重组九价HPV疫苗。临床前研究表明,在相同免疫剂量下,接种两针REC604c诱导产生的免疫原性总体优于默沙东Gardasil9三针免疫水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1576","159646","BK1583","02179","03347","BK1141"],"gpt_icon":0},{"id":"2510319924","title":"瑞科生物-B盘中异动 股价大涨5.30%报9.140港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510319924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510319924?lang=zh_cn&edition=full","pubTime":"2025-02-12 13:04","pubTimestamp":1739336684,"startTime":"0","endTime":"0","summary":"2025年02月12日下午盘13时04分,瑞科生物-B股票出现波动,股价大幅拉升5.30%。截至发稿,该股报9.140港元/股,成交量2.35万股,换手率0.01%,振幅3.92%。资金方面,该股资金流入15.393万港元,流出4.8665万港元。瑞科生物-B股票所在的生物技术行业中,整体涨幅为0.03%。其相关个股中,科笛-B、北海康成-B、药明巨诺-B涨幅较大,振幅较大的相关个股有科笛-B、北海康成-B、药明巨诺-B,振幅分别为22.41%、13.28%、11.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212130444a242c30f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212130444a242c30f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2510319441","title":"瑞科生物-B(02179)股价上升5.3%,现价港币$9.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2510319441","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510319441?lang=zh_cn&edition=full","pubTime":"2025-02-12 13:04","pubTimestamp":1739336640,"startTime":"0","endTime":"0","summary":"[上升股]瑞科生物-B(02179) 股价在下午01:04比前收市价上升5.3%,现股价为港币$9.14。至目前为止,今日最高价为$9.14,而最低价为$8.8。总成交量为2.35万股,总成交金额为港币$21.156万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502124011/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2510408458","title":"瑞科生物-B盘中异动 早盘急速上涨5.08%报8.680港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510408458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510408458?lang=zh_cn&edition=full","pubTime":"2025-02-11 10:55","pubTimestamp":1739242512,"startTime":"0","endTime":"0","summary":"2025年02月11日早盘10时55分,瑞科生物-B股票出现异动,股价大幅上涨5.08%。截至发稿,该股报8.680港元/股,成交量3.1万股,换手率0.01%,振幅7.14%。瑞科生物-B股票所在的生物技术行业中,整体跌幅为1.35%。其相关个股中,基石药业-B、华康生物医学、中国抗体-B涨幅较大,振幅较大的相关个股有基石药业-B、加科思-B、云顶新耀-B,振幅分别为9.92%、9.09%、8.29%。瑞科生物-B公司简介:江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021110551298811ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021110551298811ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2510472858","title":"瑞科生物-B(02179)股价上升5.085%,现价港币$8.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2510472858","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510472858?lang=zh_cn&edition=full","pubTime":"2025-02-11 10:55","pubTimestamp":1739242500,"startTime":"0","endTime":"0","summary":"[上升股]瑞科生物-B(02179) 股价在上午10:55比前收市价上升5.085%,现股价为港币$8.68。至目前为止,今日最高价为$8.68,而最低价为$8.09。总成交量为3.1万股,总成交金额为港币$26.258万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502111007/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2502060413","title":"瑞科生物-B盘中异动 临近收盘股价大跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502060413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502060413?lang=zh_cn&edition=full","pubTime":"2025-01-09 15:47","pubTimestamp":1736408841,"startTime":"0","endTime":"0","summary":"2025年01月09日临近收盘15时47分,瑞科生物-B股票出现异动,股价大幅下跌6.02%。截至发稿,该股报8.270港元/股,成交量1.05万股,换手率0.00%,振幅6.14%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。瑞科生物-B股票所在的生物技术行业中,整体涨幅为1.31%。瑞科生物-B公司简介:江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109154721aba43aff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109154721aba43aff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0699},{"period":"3month","weight":0.1156},{"period":"6month","weight":-0.0665},{"period":"1year","weight":-0.1422},{"period":"ytd","weight":-0.1874}],"compareEarnings":[{"period":"1week","weight":0.0093},{"period":"1month","weight":-0.0093},{"period":"3month","weight":0.1542},{"period":"6month","weight":0.2662},{"period":"1year","weight":0.3537},{"period":"ytd","weight":0.2034}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。该公司拥有一系列临床和临床前阶段的疫苗,人乳头瘤病毒(HPV)疫苗管线包括重组HPV九价候选疫苗REC603,重组HPV二价候选疫苗REC601及REC602,重组HPV四价疫苗REC604a以及重组HPV九价疫苗REC604b。该公司还参与新冠病毒疫苗的研发。该公司主要在国内市场销售其产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.071825},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.044398},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.06484},{"month":4,"riseRate":0.25,"avgChangeRate":-0.083572},{"month":5,"riseRate":0.25,"avgChangeRate":-0.027385},{"month":6,"riseRate":0.25,"avgChangeRate":-0.013774},{"month":7,"riseRate":0.25,"avgChangeRate":-0.028264},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.030435},{"month":9,"riseRate":0.333333,"avgChangeRate":0.008675},{"month":10,"riseRate":0.666667,"avgChangeRate":0.045462},{"month":11,"riseRate":0,"avgChangeRate":-0.122778},{"month":12,"riseRate":1,"avgChangeRate":0.175091}],"exchange":"SEHK","name":"瑞科生物-B","nameEN":"RECBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞科生物-B,02179,瑞科生物-B股票,瑞科生物-B股票老虎,瑞科生物-B股票老虎国际,瑞科生物-B行情,瑞科生物-B股票行情,瑞科生物-B股价,瑞科生物-B股市,瑞科生物-B股票价格,瑞科生物-B股票交易,瑞科生物-B股票购买,瑞科生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}